tbuckley/cabot-search huggingface dataset:
Prescriber Profiling
Authors: Adriane Fugh-Berman
Journal: Annals of Internal Medicine (2008)

Letters1 January 2008Prescriber ProfilingAdriane Fugh-Berman, MDAdriane Fugh-Berman, MDFrom Georgetown University School of Medicine, Washington, DC 20057-1460.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-148-1-200801010-00015 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Grande notes that participation in the AMA's PDRP has been low (1). Widespread participation, however, would constitute only a minor impediment to prescription tracking. The PDRP restricts only drug representatives and their immediate supervisors from accessing brand-specific prescribing information for individual physicians (2). Any pharmaceutical company employees above that level have full access to details of physicians' prescribing habits. The restrictions also do not apply to “deciles at the market or therapeutic class level” (2), which means that drug representatives still have access to specific information, for example, that Dr. X prescribes more antidepressants than 90% of ...References1. Grande D. Prescriber profiling: time to call it quits [Editorial]. Ann Intern Med. 2007;146:751-2. [PMID: 17502637] LinkGoogle Scholar2. Musacchio RJ, Hunkler RA. More than a game of keep away. Pharmaceutical Executive. 2006;May 1. Accessed at www.ama-assn.org/ama1/pub/upload/mm/432/pdrppharexecmay06.pdf on 25 May 2007. Google Scholar3. American Medical Association. Physician Data Restriction Program. Accessed at www.ama-assn.org/ama/pub/category/12054.html on 22 October 2007. Google Scholar Author, Article, and Disclosure InformationAffiliations: From Georgetown University School of Medicine, Washington, DC 20057-1460.Disclosures: Dr. Fugh-Berman has been a paid expert witness on the plaintiff's side in litigation regarding pharmaceutical marketing practices. She directs PharmedOut.org, a project funded through the Attorney General Consumer and Prescriber Grant Program. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoPharmaceutical Marketing Research and the Prescribing Physician Jeremy A. Greene Prescriber Profiling: Time to Call It Quits David Grande Prescriber Profiling Alexander C. Tsai Prescriber Profiling Stephen E. Pratt Prescriber Profiling Stephen M. Kirk Metrics Cited ByExpert cardiologists cannot distinguish between Brugada phenocopy and Brugada syndrome electrocardiogram patterns 1 January 2008Volume 148, Issue 1Page: 82KeywordsAntidepressantsAntipsychoticsConflicts of interestDrugsHabits ePublished: 1 January 2008 Issue Published: 1 January 2008 CopyrightCopyright © 2008 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...
Table of Contents
Journal: JAMA (1973)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Heterozygous carriers of ABCB4 mutations show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma – a cohort study
Authors: Marta Mazzetti, Elsemieke de Vries, Bart Takkenberg, Nahid Mostafavi, Henny Bikker, Marco Marzioni, Rozanne de Veer, Adriaan Van der Meer, Michael Doukas, Joanne Verheij, Ulrich Beuers
Journal: Journal of Hepatology (2020)
HEMOPHILIA CONTRIBUTIONS
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Misidentification of Patients in the Abstract and Author Affiliations
Authors: Caroline Meade, Connor Drake, Ralph Snyderman
Journal: JAMA (2016)

Prashant Mahajan, MD, MPH, MBA; Nathan Kuppermann, MD, MPH; Asuncion Mejias, MD, PhD; Nicolas Suarez, PhD; Damien Chaussabel, PhD; T. Charles Casper, PhD; Bennett Smith, BS; Elizabeth R. Alpern, MD, MSCE; Jennifer Anders, MD; Shireen M. Atabaki, MD, MPH; Jonathan E. Bennett, MD; Stephen Blumberg, MD; Bema Bonsu, MD; Dominic Borgialli, DO, MPH; Anne Brayer, MD; Lorin Browne, DO; Daniel M. Cohen, MD; Ellen F. Crain, MD, PhD; Andrea T. Cruz, MD, MPH; Peter S. Dayan, MD, MSc; Rajender Gattu, MD; Richard Greenberg, MD; John D. Hoyle Jr, MD; David M. Jaffe, MD; Deborah A. Levine, MD; Kathleen Lillis, MD; James G. Linakis, MD, PhD; Jared Muenzer, MD; Lise E. Nigrovic, MD, MPH; Elizabeth C. Powell, MD, MPH; Alexander J. Rogers, MD; Genie Roosevelt, MD; Richard M. Ruddy, MD; Mary Saunders, MD; Michael G. Tunik, MD; Leah Tzimenatos, MD; elissa Vitale, MD; J. Michael Dean, MD, MBA; Octavio Ramilo, MD; for the Pediatric Emergency Care Applied Research Network (PECARN)
new developments in cancer
Journal: CA A Cancer Journal for Clinicians (1958)

Tobacco a Cocarcinogen? ---In experiments at Columbia University, tars obtained from cigarettes burned at 500-700@ F. failed to produce cancer when applied to the mouse skin.In combination with the common carcinogen, however.the tars produced significantly more papil lomas and cancers than benzpyrene alone.In this role, tobacco tar proved to be more cocarcinogenic than is croton oil.The in vestigator, Dr. Alfred Gellhorn, offers the results as circumstantial evidence that air pollution and cigarette smoking may have synergistic or additive effects in produc ing lung cancer.
Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery
Authors: Loïc Sentilhes, Marie V. Sénat, Maëla Le Lous, Norbert Winer, Patrick Rozenberg, Gilles Kayem, Eric Verspyck, Florent Fuchs, Elie Azria, Denis Gallot, Diane Korb, Raoul Desbrière, Camille Le Ray, Céline Chauleur, Fanny de Marcillac, Franck Perrotin, Olivier Parant, Laurent J. Salomon, Emilie Gauchotte, Florence Bretelle, Nicolas Sananès, Caroline Bohec, Nicolas Mottet, Guillaume Legendre, Vincent Letouzey, Bassam Haddad, Delphine Vardon, Hugo Madar, Aurélien Mattuizzi, Valérie Daniel, Sophie Regueme, Caroline Roussillon, Antoine Benard, Aurore Georget, Astrid Darsonval, Catherine Deneux-Tharaux
Journal: New England Journal of Medicine (2021)

Prophylactic administration of tranexamic acid has been associated with reduced postpartum blood loss after cesarean delivery in several small trials, but evidence of its benefit in this clinical context remains inconclusive.
Dominant Lethal Studies with the Halogenated Olefins Vinyl Chloride and Vinylidene Dichloride in Male CD-1 Mice
Authors: Diana Anderson, M. C. E. Hodge, I. F. H. Purchase
Journal: Environmental Health Perspectives (1977)

The mutagenic activity of vinyl chloride (VC) and vinylidene dichloride (VDC) at three exposure levels was assessed in fertile male CD-1 mice with the dominant lethal test. Each compound was assessed in a separate study. Male mice were exposed by inhalation to VC at 3000, 10,000, and 30,000 ppm and to VDC at 10, 30, and 50 ppm for 6 hr/day for 5 days. By comparison with control males exposed to air, no mutagenic effects on any maturation stage of spermatogenesis in treated males were detected. There was no significant increase in the number of postimplantational early fetal deaths as shown by the number of females with one or more early deaths or the number of early deaths/pregnancy or the number of early deaths/total implants/pregnancy. There was no evidence of pre-implantational egg losses as indicated by the total implants/pregnant female. There was also no reduction in fertility. (The reduction in fertility at 50 ppm VDC was unproven). The lack of effect was not due to the insensitivity of the system used, since both the VC and VDC study a mutagenic effect was clearly demonstrated in male mice dosed IP with the positive control compounds cyclophosphamide (CTX) and/or ethylmethane sulfonate (EMS). During dosing these animals were housed under similar exposure conditions to those animals exposed to the test substances but with a flow of air through the exposure chambers. Thus, neither VC nor VDC is mutagenic in the mouse at the stated exposure levels as measured by the dominant lethal test.
CELEBRATION OF THE INTRODUCTION OF ANESTHETICS.
Journal: JAMA (1896)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Acute epiglottitis in adults
Authors: R. H. Ossoff
Journal: JAMA (1980)

Epiglottitis occurs more often in adults than is generally recognized. Six adults with epiglottitis were treated at Evanston (III) Hospital from March to August 1978. Two required tracheostomy because of delayed diagnosis. There were no deaths. This experience suggests that any patient with acute, painful dysphagia should have indirect laryngoscopy or a carefully interpreted lateral roentgenogram of the neck to rule out epiglottitis. (<i>JAMA</i>1980;244:2639-2640)
HOMICIDE BY MICROBES.
Journal: JAMA (1898)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Measles Outbreak — Chicago, 1989
Journal: JAMA (1989)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Commentary
Authors: J D Perry
Journal: British Journal of Sports Medicine (2000)

Von Willebrand's disease is a relatively common mild form of haemophilia.It should be suspected in assessing sports injuries when excessive bleeding occurs in response to relatively mild trauma.Those with the disease should remain active but avoid contact sports.They should not take aspirin or non-steroidal antiinflammatory drugs, which may exacerbate bleeding, and should be given supportive treatment to cover dental extraction, surgery, or significant bleeding episodes.
Medical Teachers
Authors: K. M. Lawrence, J. P. D. Thomas, A. Jacobs, A. W. Asscher, S. W. Williams, J. L. Withey, J. G. Leopold, J. M. Pexton, H. J. Whiteley, E. E. Payne, A. M. George, C. C. Entwistle, T. D. Brogan, H. Campbell, G. M. Mitchell, J. H. Lawrie, M. Sussman, J. F. Bates
Journal: BMJ (1966)
Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity
Authors: M. S. Magee
Journal: JAMA (1993)

<h3>Objective.</h3> —To determine the incidence of gestational diabetes and its associated maternal and infant morbidity by two sets of 3-hour glucose tolerance test criteria, those recommended by the National Diabetes Data Group or the lower, modified criteria of Carpenter and Coustan. <h3>Design.</h3> —Prospective, observational outcome cohort study. <h3>Setting.</h3> —Prepaid health maintenance organization. <h3>Subjects.</h3> —A total of 2019 pregnant women preregistered in a health maintenance organization were screened for a plasma glucose of 7.77 mmol/L (140 mg/ dL) or greater, 1 hour after ingestion of a 50-g glucose drink administered after an overnight fast. Positive subjects received a 3-hour glucose tolerance test interpreted by the two criteria. Data are presented for 521 randomly selected negative screenees; 264 positive screen, negative glucose tolerance test subjects; and 101 subjects with gestational diabetes mellitus. <h3>Outcome Measures.</h3> —Maternal risk factors for diabetes, infant birth weight corrected for gestational age (birth-weight ratio), umbilical cord serum insulin levels, and 33 maternal and infant perinatal morbidities assessed from chart review. <h3>Results.</h3> —Gestational diabetes incidence was 5.0% overall based on the modified criteria and 3.2% by the recommended criteria. Maternal age and family history of diabetes were higher in both modified and recommended groups. Birth-weight ratio was 1.05 in negative screenees, 1.09 in gestational diabetes overall (<i>P</i>&lt;.05 when only diet-treated subjects were considered), and 1.11 in modified and 1.08 in recommended criteria groups. Cord serum insulin levels in infants of gestational diabetic mothers by both criteria were 40% above those of negative screenees (<i>P</i>&lt;.001). The average percentage incidence of 33 possible perinatal morbidities was 41% higher in gestational diabetic pregnancies by the modified criteria. The cumulative number of morbidities was higher in both modified and recommended criteria groups (<i>P</i>&lt;.01 in both instances). In contrast, subjects having a positive glucose screening test but a negative glucose tolerance test by modified criteria had none of the characteristics of gestational diabetes with the single exception of greater age. <h3>Conclusions.</h3> —Fifty percent more cases of gestational diabetes were identified using the more inclusive, modified criteria. These cases had as much excess in maternal diabetes risk factors, infant macrosomia, and cord hyperinsulinemia and nearly as much increase in perinatal morbidity as subjects diagnosed by the recommended criteria. The incidence and perinatal impact of gestational diabetes may be greater than previously appreciated. The modified criteria deserve wider verification and use. (<i>JAMA</i>. 1993;269:609-615)
Combined therapy for chloroquine-resistant, Plasmodium falciparum infection. Concurrent use of long-acting sulphormethoxine and pyrimethamine
Authors: P. J. Bartelloni
Journal: JAMA (1967)

Combined therapy with a single dose of the long-acting sulfonamides, sulphormethoxine, and pyrimethamine was found to be effective alone and in combination with quinine sulfate for treatment of<i>Plasmodium falciparum</i>infections in nonimmune patients. While combined chloroquine-quinine therapy was usually effective in control of clinical disease, 41% of the patients had recrudescences shortly after therapy was completed (14.3 days). In contrast, only 2% of the patients treated with sulphormethoxine, pyrimethamine, and quinine had a reappearance of clinical disease. Five nonimmune patients had a clinical cure of their primary infection following a single dose of the sulphormethoxine-pyrimethamine combination.
Anti–PD-1–CTLA4 Combo Hits Prostate Cancer
Journal: Cancer Discovery (2019)

Combining nivolumab and ipilimumab may be an effective treatment strategy for metastatic castration-resistant prostate cancer. In a phase II trial, 25% of patients who received the combination following hormone therapy had an objective response. However, the combination was associated with considerable side effects that caused many patients to discontinue treatment.
A Research Agenda for Malaria Eradication: Cross-Cutting Issues for Eradication
Journal: PLoS Medicine (2011)

Discipline-specific Malaria Eradication Research Agenda (malERA) Consultative Groups have recognized several cross-cutting issues that must be addressed to prevent repetition of some of the mistakes of past malaria elimination campaigns in future programs. Integrated research is required to develop a decision-making framework for the switch from malaria control to elimination. Similarly, a strong economic case is needed for the very long-term financial support that is essential for elimination. Another cross-cutting priority is the development of improved measures of intensity of transmission, especially at low and nonrandom levels. Because sustained malaria elimination is dependent on a functioning health system, a further key cross-cutting research question is to determine how inputs for malaria can strengthen health systems, information systems, and overall health outcomes. Implementation of elimination programs must also be accompanied by capacity building and training to allow the assessment of the impact of new combinations of interventions, new roles for different individuals, and the operational research that is needed to facilitate program expansion. Finally, because community engagement, knowledge management, communication, political, and multisectoral support are critical but poorly understood success factors for malaria elimination, integrated research into these issues is vital.
THE VENEREAL PERIL.
Journal: JAMA (1906)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Self-Induced Malaria Associated With Malariotherapy for Lyme Disease—Texas
Journal: JAMA (1991)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal